Daniel L. Kastner
Daniel L. Kastner (born 1951) is an American physician and researcher specialising in the genetics of autoinflammatory disorders. He is scientific director of the National Human Genome Research Institute, where he is a National Institutes of Health Distinguished Investigator. He was awarded the 2021 Crafoord Prize for Polyarthritis for his pioneering work on autoinflammatory diseases. Early life and education. Kastner was born in Lockport, NY, in 1951. Kastner earned a BA in philosophy from Princeton University in 1973. and an MD and PhD from Baylor College of Medicine. Career. Kastner joined the National Institutes of Health in  1985 and is scientific director of the Division of Intramural Research of the National Human Genome Research Institute. His research there "has focused on using genetic and genomic strategies to understand inherited disorders of inflammation". His work has led to the recognition and treatment of a range of autoinflammatory disorders. In 1987 his was one of two teams which simultaneously discovered and published the genetic mutation which causes FMF, and since then he has worked on disorders including TRAPS and DADA2. In 2020 he was one of the authors of the paper which first described the VEXAS syndrome. he is  working on Behçet's disease. The chair of the Crafoord Prize committee, , said in 2021:Dan Kastner is often called the father of autoinflammatory diseases, a title that he thoroughly deserves. His discoveries have taught us a great deal about the immune system and its functions, contributing to effective treatments that reduce the symptoms of diseases from which patients previously suffered enormously, sometimes leading to premature death Honors and recognition. Kastner was elected to the National Academy of Sciences in 2010 and to the National Academy of Medicine in 2012. In 2018 Kastner was named "Federal Employee of the Year  in the Samuel J. Heyman Service to America Medals (the Sammies"). and in 2019 he won the Ross Prize for Molecular Medicine. He was awarded the 2021 Crafoord Prize in Polyarthritis, with the citation "for establishing the concept of autoinflammatory diseases".